Glucotrack, Inc. Files 8-K with Corporate Updates

Ticker: GCTK · Form: 8-K · Filed: Aug 27, 2024 · CIK: 1506983

Glucotrack, INC. 8-K Filing Summary
FieldDetail
CompanyGlucotrack, INC. (GCTK)
Form Type8-K
Filed DateAug 27, 2024
Risk Levellow
Pages2
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: corporate-filing, 8-K, company-update

Related Tickers: GCTK

TL;DR

Glucotrack (GCTK) filed an 8-K on Aug 27, updating its address and former names.

AI Summary

Glucotrack, Inc. filed an 8-K on August 27, 2024, to report on Regulation FD disclosures and financial statements. The filing details the company's principal executive offices located at 301 Rte 17 North, Ste. 800, Rutherford, NJ 07070. The company was formerly known as Integrity Applications, Inc. until a name change on March 28, 2022.

Why It Matters

This filing provides essential corporate information and updates for Glucotrack, Inc., including its current address and former company names, which is important for investors and stakeholders tracking the company's history and structure.

Risk Assessment

Risk Level: low — The filing is a routine corporate disclosure and does not contain information that inherently increases risk.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Glucotrack, Inc.?

The primary purpose is to report on Regulation FD disclosures and financial statements, as well as provide updated corporate information.

What is Glucotrack, Inc.'s current principal executive office address?

The principal executive offices are located at 301 Rte 17 North, Ste. 800, Rutherford, NJ 07070.

When did Glucotrack, Inc. change its name?

The company changed its name on March 28, 2022.

What was Glucotrack, Inc. formerly known as?

Glucotrack, Inc. was formerly known as Integrity Applications, Inc.

What is the filing date of this 8-K report?

The report was filed on August 27, 2024.

Filing Stats: 480 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2024-08-27 09:12:54

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 27, 2024 GLUCOTRACK, INC. By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing